Technical Analysis for IDNA - iShares Genomics Immunology and Healthcare ETF
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 22.43 | 1.82% | 0.40 |
IDNA closed up 1.47 percent on Monday, April 22, 2024, on 57 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Slingshot Bearish | Bearish Swing Setup | 1.82% | |
| Crossed Above 200 DMA | Bullish | 1.82% | |
| Spinning Top | Other | 1.82% | |
| Lower Bollinger Band Walk | Weakness | 1.82% | |
| Gapped Up | Strength | 1.82% | |
| Oversold Stochastic | Weakness | 1.82% | |
| 200 DMA Resistance | Bearish | 3.32% | |
| Stochastic Buy Signal | Bullish | 3.32% | |
| Lower Bollinger Band Walk | Weakness | 3.32% | |
| Down 3 Days in a Row | Weakness | 3.32% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | about 2 hours ago |
| Up 2% | about 2 hours ago |
| Up 1 ATR | about 2 hours ago |
| Rose Above 10 DMA | about 3 hours ago |
| 2x Volume Pace | about 3 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
The investment seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.
Keywords: Exchange Traded Fund Immunology Genomics
Classification
Keywords: Exchange Traded Fund Immunology Genomics
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 25.2557 |
| 52 Week Low | 17.2113 |
| Average Volume | 35,828 |
| 200-Day Moving Average | 21.93 |
| 50-Day Moving Average | 23.56 |
| 20-Day Moving Average | 23.02 |
| 10-Day Moving Average | 22.48 |
| Average True Range | 0.40 |
| RSI (14) | 34.21 |
| ADX | 21.58 |
| +DI | 16.55 |
| -DI | 36.02 |
| Chandelier Exit (Long, 3 ATRs) | 23.28 |
| Chandelier Exit (Short, 3 ATRs) | 22.74 |
| Upper Bollinger Bands | 24.49 |
| Lower Bollinger Band | 21.54 |
| Percent B (%b) | 0.17 |
| BandWidth | 12.79 |
| MACD Line | -0.49 |
| MACD Signal Line | -0.35 |
| MACD Histogram | -0.1446 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 22.63 | ||||
| Resistance 3 (R3) | 22.62 | 22.40 | 22.53 | ||
| Resistance 2 (R2) | 22.40 | 22.25 | 22.41 | 22.50 | |
| Resistance 1 (R1) | 22.22 | 22.16 | 22.31 | 22.23 | 22.46 |
| Pivot Point | 22.00 | 22.00 | 22.05 | 22.01 | 22.00 |
| Support 1 (S1) | 21.82 | 21.85 | 21.91 | 21.83 | 21.60 |
| Support 2 (S2) | 21.60 | 21.76 | 21.61 | 21.56 | |
| Support 3 (S3) | 21.42 | 21.60 | 21.53 | ||
| Support 4 (S4) | 21.43 |
